UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: ' | A | B | C | D | E | F | G | H | I | K | L | M | N | O | P | Q | R | S | T | U | V | W | Y | Z
Number of items: 244.

'

't Hoen, PAC; van der Wees, CGC; Aartsma-Rus, A; Turk, R; Goyenvalle, A; Danos, O; Garcia, L; ... van Deutekom, JCT; + view all (2006) Gene expression profiling to monitor therapeutic and adverse effects of antisense therapies for Duchenne muscular dystrophy. Pharmacogenomics , 7 (3) pp. 281-297. 10.2217/14622416.7.3.281.

A

Allen, A.J.R.; (2006) Investigations into the pathogenesis of essential thrombocythemia. Doctoral thesis , University of London. Green open access
file

Ancliff, PJ; Blundell, MP; Cory, GO; Calle, Y; Worth, A; Kempski, H; Burns, S; ... Thrasher, AJ; + view all (2006) Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia. Blood , 108 (7) pp. 2182-2189. 10.1182/blood-2006-01-010249.

Ancliff, PJ; Blundell, MP; Cory, GO; Calle, Y; Worth, A; Kempski, H; Burns, S; ... Thrasher, AJ; + view all (2006) Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia. BLOOD , 108 (7) 2182 - 2189.

Austin, S; Cohen, H; (2006) Antiphospholipid syndrome. Medicine , 34 (11) pp. 472-475. 10.1053/j.mpmed.2006.08.012.

Austin, SK; Lawrie, AS; Starke, RD; Scully, M; Machin, SJ; Cohen, H; Mackie, IJ; (2006) ADAMTS13 antibodies in patients with antiphospholipid antibodies. Presented at: 46th Annual Scientific Meeting of the British-Society-for-Haematology, Edinburgh, SCOTLAND.

Austin, SK; Lawrie, AS; Starke, RD; Scully, M; Machin, SJ; Cohen, H; Mackie, IJ; (2006) ADAMTS13 antibodies in patients with antiphospholipid antibodies. In: (pp. p. 94).

Austin, SK; Starke, RD; Purdy, G; Lawrie, AS; Machin, SJ; Mackie, IJ; (2006) High affinity autoantibodies to ADAMTS13 in the antiphospholipid syndrome. In: BLOOD. (pp. 424A - 424A). AMER SOC HEMATOLOGY

B

Baker, RJ; Hughes, DA; Ioannidis, A; Milligan, A; Blincoe, M; Mehta, AB; (2006) Measurement of alpha-galactosidase A activity in tears. Presented at: UNSPECIFIED.

Batten, P; Sarathchandra, P; Antoniw, JW; Tay, SS; Lowdell, MW; Taylor, PM; Yacoub, MH; (2006) Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: Relevance to tissue engineering human heart valves. TISSUE ENG , 12 (8) 2263 - 2273.

Beck, M; Cox, TM; Gal, A; Mehta, AB; (2006) Lysosomal Diseases, Natural Course, Pathophysiology and Therapy. [Book]. (Vol.96, su). Blackwell

Benjamin, R; Davidoff, AM; Singh, N; Mcintosh, J; Khwaja, A; Streck, C; Ng, C; ... Nathwani, AC; + view all (2006) Therapeutic efficacy of interferon-beta in a xenograft model of acute myeloid leukaemia. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 62 - 63). BLACKWELL PUBLISHING

Benyo, Z; Gille, A; Bennett, CL; Clausen, BE; Offermanns, S; (2006) Nicotinic acid-induced flushing is mediated by activation of epidermal langerhans cells. MOLECULAR PHARMACOLOGY , 70 (6) pp. 1844-1849. 10.1124/mol.106.030833.

Betticher, DC; Martinelli, G; Radford, JA; Kaufmann, M; Dyer, MJS; Kaiser, U; Aulitzky, WE; ... Linch, DC; + view all (2006) Sequential high dose chemotherapy as initial treatment for aggressive sub-types of Non-Hodgkin Lymphoma: results of the international randomized phase III trial (MISTRAL). ANN ONCOL , 17 (10) 1546 - 1552. 10.1093/annonc/mdl153.

Billottet, C; Grandage, VL; Gale, RE; Quattropani, A; Rommel, C; Vanhaesebroeck, B; Khwaja, A; (2006) A selective inhibitor of the p110 delta isoform of PI 3-kinase inhibits AML cell proliferation and survival and increases the cytotoxic effects of VP16. ONCOGENE , 25 (50) 6648 - 6659. 10.1038/sj.onc.1209670.

Bishton, MJ; Lush, R; Russell, NH; Shaw, BE; Haynes, AP; (2006) Ifosphamide, etoposide and epirubicin (IVE) is an effective combined salvage and peripheral blood stem cell mobilisation regimen for transplant-eligible patients with lymphoma. In: BLOOD. (pp. 688A - 688A). AMER SOC HEMATOLOGY

Bloor, AJC; Ahmed, O; Dimpoulou, M; Fielding, AK; Chakraverty, R; Parker, AN; Liakopoulou, E; ... Kottaridis, P; + view all (2006) Reduced intensity allogeneic stem cell transplantation in patients with myelofibrosis. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 13 - 13). BLACKWELL PUBLISHING

Bloor, AJC; Mackinnon, S; (2006) Cerebral tuberculosis post stem cell transplant. Eur J Haematol , 77 (5) 456-. 10.1111/j.1600-0609.2006.00718.x.

Bowen, D; Hyslop, A; Keenan, N; Groves, M; Culligan, D; Johnson, P; Shaw, A; ... Cavill, I; + view all (2006) Predicting erythroid response to recombinant erythropoietin plus granulocyte colony-stimulating factor therapy following a single subcutaneous bolus in patients with myelodysplasia. HAEMATOL-HEMATOL J , 91 (5) 709 - 710. Gold open access

Brissault, B; Kichler, A; Leborgne, C; Danos, O; Cheradame, H; Gau, J; Auvray, L; (2006) Synthesis, characterization, and gene transfer application of poly(ethylene glycol-b-ethylenimine) with high molar mass polyamine block. Biomacromolecules , 7 (10) pp. 2863-2870. 10.1021/bm060499a.

Brissault, B; Leborgne, C; Guis, C; Danos, O; Cheradame, H; Kichler, A; (2006) Linear topology confers in vivo gene transfer activity to polyethylenimines. Bioconjug Chem , 17 (3) pp. 759-765. 10.1021/bc050287v.

Burckbuchler, V; Wintgens, V; Lecomte, S; Percot, A; Leborgne, C; Danos, O; Kichler, A; (2006) DNA compaction into new DNA vectors based on cyclodextrin polymer: surface enhanced Raman spectroscopy characterization. Biopolymers , 81 (5) pp. 360-370. 10.1002/bip.20428.

Burton, C; Linch, D; Hoskin, P; Milligan, D; Dyer, MJS; Hancock, B; Mouncey, P; ... Cunningham, D; + view all (2006) A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma. British Journal of Cancer , 94 (6) pp. 806-813. 10.1038/sj.bjc.6602975.

C

Cappellini, MD; Cohen, A; Piga, A; Bejaoui, M; Perrone, S; Agaoglu, L; Aydinok, Y; ... Alberti, D; + view all (2006) A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. BLOOD , 107 (9) 3455 - 3462. 10.1182/blood-2005-08-3430.

Cappellini, MD; Cohen, A; Piga, A; Bejaoui, M; Perrotta, S; Agaoglu, L; Aydinok, Y; ... Alberti, D; + view all (2006) Aphase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with β-thalassemia. Blood , 107 (9) pp. 3455-3462. 10.1182/blood-2005-08-3430.

Cappellini, MD; Giardina, P; Porter, J; Coates, T; Della Porta, MG; Siegel, J; Glimm, E; ... Cappellini, MD; + view all (2006) Long-term safety and tolerability of the once-daily, oral iron chelator deferasirox (Exjade (R), ICL670) in patients with transfusional iron overload. In: BLOOD. (pp. 501A - 501A). AMER SOC HEMATOLOGY

Cardigan, R; Lawrie, A; Mackie, I; Williamson, L; (2006) Effect of overnight 4 degrees C storage of whole blood on von Willebrand factor: reply. TRANSFUSION , 46 (6) 1059 - 1060.

Carmo, M; Faria, TQ; Falk, H; Coroadinha, AS; Teixeira, M; Merten, O-W; Gény-Fiamma, C; ... Cruz, PE; + view all (2006) Relationship between retroviral vector membrane and vector stability. J Gen Virol , 87 (Pt 5) pp. 1349-1356. 10.1099/vir.0.81302-0.

Caswell, R; Warner, TT; Mehta, A; Ginsberg, L; (2006) POEMS syndrome. Practical Neurology , 6 pp. 14-26.

Chakraverty, R; Cote, D; Buchli, J; Cotter, P; Hsu, R; Zhao, GL; Sachs, T; ... Sykes, M; + view all (2006) An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues. J EXP MED , 203 (8) 2021 - 2031. 10.1084/jem.20060376. Green open access
file

Chakraverty, R; Dimopoulou, M; Glanville, J; Thomson, K; Peggs, K; Milligan, D; Cook, G; ... Mackinnon, S; + view all (2006) De-Escalation of the Alemtuzumab Dose Prior to Nonmyeloablative HLA-Identical Sibling Transplantation: Crucial Role of Timing. In: (Proceedings) American Society of Haematology.

Chakraverty, R; Dimopoulou, M; Glanville, J; Thomson, K; Peggs, K; Milligan, D; Cook, G; ... Mackinnon, S; + view all (2006) De-escalation of the alemtuzumab dose prior to nonmyeloablative HLA-identical sibling transplantation: Crucial role of timing. In: BLOOD. (pp. 821A - 822A). AMER SOC HEMATOLOGY

Chakraverty, R.; Eom, H.; Sachs, J.; Buchli, J.; Cotter, P.; Hsu, R.; Zhao, G.; (2006) Host MHC class II+ antigen-presenting cells and CD4 cells are required for CD8-mediated graft-versus-leukemia responses following delayed donor leukocyte infusions. Blood , 108 (6) pp. 2106-2113. 10.1182/blood-2006-03-007427.

Chantrain, CF; Bruwier, A; Brichard, B; Largent, V; Chapgier, A; Feinberg, J; Casanova, JL; ... Vermylen, C; + view all (2006) Successful hematopoietic stem cell transplantation in a child with active disseminated Mycobacterium fortuitum infection and interferon-gamma receptor 1 deficiency. BONE MARROW TRANSPLANTATION , 38 (1) pp. 75-76. 10.1038/sj.bmt.1705399.

Chantry, AD; Snowden, JA; Craddock, C; Peggs, K; Roddie, C; Craig, JIO; Orchard, K; ... Marks, DI; + view all (2006) Long-term outcomes of myeloablation and autologous transplantation of relapsed acute myeloid leukemia in second remission: A British Society of Blood and Marrow Transplantation registry study. BIOL BLOOD MARROW TR , 12 (12) 1310 - 1317. 10.1016/j.bbmt.2006.07.015.

Chapgier, A; Boisson-Dupuis, S; Jouanguy, E; Vogt, G; Feinberg, J; Prochnicka-Chalufour, A; Casrouge, A; ... Casanova, JL; + view all (2006) Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease. PLoS Genetics , 2 (8) e131 -. 10.1371/journal.pgen.0020131. Green open access
file

Chapgier, A; Wynn, RF; Jouanguy, E; Filipe-Santos, O; Zhang, S; Feinberg, J; Hawkins, K; ... Arkwright, PD; + view all (2006) Human complete Stat-1 deficiency is associated with defective type I and IIIFN responses in vitro but immunity to some low virulence viruses in vivo. JOURNAL OF IMMUNOLOGY , 176 (8) pp. 5078-5083. 10.4049/jimmunol.176.8.5078.

Chapman, CE; Williamson, LM; Cohen, H; Stainsby, D; Jones, H; (2006) The impact of using male donor plasma on haemovigilance reports of transfusion related acute lung injury (TRALI) in the UK. Presented at: UNSPECIFIED.

Coakley, M; Reddy, K; Mackie, I; Mallett, S; (2006) Transfusion triggers in orthotopic liver transplantation: A comparison of the thromboelastometry analyzer, the thromboelastogram, and conventional coagulation tests. J CARDIOTHOR VASC AN , 20 (4) 548 - 553. 10.1053/j.jvca.2006.01.016.

Cohen, H; Austin, SK; Lawrie, AS; Starke, RD; Scully, M; Machin, S; Cohen, H; (2006) ADAMTS13 antibodies in patients with antiphospholipid antibodies. In:

Collin, MP; Hart, DNJ; Jackson, GH; Cook, G; Cavet, J; Mackinnon, S; Middleton, PG; (2006) The fate of human Langerhans cells in hematopoietic stem cell transplantation. J EXP MED , 203 (1) 27 - 33. 10.1084/jem.20051787.

Cook, G; Clark, RE; Crawley, C; Mackinnon, S; Russell, N; Thomson, K; Pearce, RM; ... Marks, DI; + view all (2006) The outcome of sibling and unrelated donor allogeneic stem cell transplantation in adult patients with acute myeloid leukemia in first remission who were initially refractory to first induction chemotherapy. BIOL BLOOD MARROW TR , 12 (3) 293 - 300. 10.1016/j.bbmt.2005.10.019.

Cutillas, PR; Khwaja, A; Graupera, M; Pearce, W; Gharbi, S; Waterfield, M; Vanhaesebroeck, B; (2006) Ultrasensitive and absolute quantification of the phosphoinositide 3-kinase/Akt signal transduction pathway by mass spectrometry. P NATL ACAD SCI USA , 103 (24) 8959 - 8964. 10.1073/pnas.0602101103. Gold open access

D

Dachs, GU; Steele, AJ; Coralli, C; Kanthou, C; Brooks, AC; Gunningham, SP; Currie, MJ; ... Tozer, GM; + view all (2006) Anti-vascular agent Combretastatin A-4-P modulates Hypoxia Inducible Factor-1 and gene expression. BMC Cancer , 6 , Article 280. 10.1186/1471-2407-6-280. Green open access
file

Danos, O; Svinartchouk, F; (2006) Dialysis-assisted two-dimensional gel electrophoresis. Electrophoresis , 27 (17) pp. 3475-3479. 10.1002/elps.200500036.

Das-Gupta, EP; Byrne, JL; Gilyead, M; Shaw, BE; Russell, NH; (2006) Long-term results of pre-transplant in vivo alemtuzumab for unrelated donor transplantation in acute myeloid leukaemia. In: BONE MARROW TRANSPLANTATION. (pp. S116 - S116). NATURE PUBLISHING GROUP

De Santis, D; Witt, C; Gomez-Lozano, N; Vilches, C; Garcia, CA; Marsh, SGE; Williams, F; ... Christiansen, F; + view all (2006) A multi-laboratory evaluation of reference cells for KIR typing. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 1233-1236). IHWG Press: Seattle.

Deegan, PB; Baehner, AF; Romero, MAB; Hughes, DA; Kampmann, C; Beck, M; (2006) Natural history of Fabry disease in females in the Fabry outcome survey. JOURNAL OF MEDICAL GENETICS , 43 (4) pp. 347-352. 10.1136/jmg.2005.036327.

Delgado, J; Cooper, N; Thomson, K; Duarte, R; Jarmulowicz, M; Cassoni, A; Kortaridis, P; ... Mackinnon, S; + view all (2006) The importance of age, fludarabine, and total body irradiation in the incidence and severity of chronic renal failure after allogeneic hematopoietic cell transplantation. BIOL BLOOD MARROW TR , 12 (1) 75 - 83. 10.1016/j.bbmt.2005.08.036.

Delgado, J; Thomson, K; Russell, N; Ewing, J; Stewart, W; Cook, G; Devereux, S; ... Milligan, DW; + view all (2006) Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation Study. BLOOD , 107 (4) 1724 - 1730. 10.1182/blood-2005-08-3372.

Descamps, MJL; Barrett, L; Groves, M; Yung, L; Birch, R; Murray, NMF; Linch, DC; ... Reilly, MM; + view all (2006) Primary sciatic nerve lymphoma: A case report and review of the literature. Journal of Neurology, Neurosurgery and Psychiatry , 77 (9) pp. 1087-1089. 10.1136/jnnp.2006.087577.

Descamps, MJL; Barrett, L; Groves, M; Yung, L; Birch, R; Murray, NMF; Linch, DC; ... Reilly, MM; + view all (2006) Primary sciatic nerve lymphoma: a case report and review of the literature. J NEUROL NEUROSUR PS , 77 (9) 1087 - 1089. 10.1136/jnnp.2006.087577.

Desigan, S; Hall-Craggs, MA; Ho, CP; Eliahoo, J; Porter, JB; (2006) Degenerative disc disease as a cause of back pain in the thalassaemic population: a case-control study using MRI and plain radiographs. SKELETAL RADIOL , 35 (2) 95 - 102. 10.1007/s00256-005-0020-1.

Duarte, RF; Pamphilon, D; Cornish, J; Shaw, BE; Samson, D; Craddock, C; Marks, D; ... Goldman, JM; + view all (2006) Topical issues in unrelated donor haematopoietic stem cell transplants: a report from a workshop convened by the Anthony Nolan Trust in London - 2005. BONE MARROW TRANSPL , 37 (10) 901 - 908. 10.1038/sj.bmt.1705365.

de Laat, B; Derksen, RHWM; Mackie, IJ; Roest, M; Schoormans, S; Woodhams, BJ; de Groot, PG; (2006) Annexin A5 polymorphism (-1C -> T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndrome. ANN RHEUM DIS , 65 (11) 1468 - 1472. 10.1136/ard.2005.045237.

E

Ellis, SA; Bontrop, RE; Antczak, DF; Ballingall, K; Davies, CJ; Kaufman, J; Kennedy, LJ; ... Marsh, SGE; + view all (2006) ISAG/IUIS-VIC Comparative MHC Nomenclature Committee report, 2005. IMMUNOGENETICS , 57 (12) pp. 953-958. 10.1007/s00251-005-0071-4.

Enver, T; Tsuzuki, S; Brown, J; Hong, D; Gupta, R; Ford, A; Egguchi, MI; ... Greaves, M; + view all (2006) Developmental impact of leukemic fusion genes on stem cell fate. Ann N Y Acad Sci. , 1044 pp. 16-23. 10.1196/annals.1349.003.

Everington, TF; Henderson, S; Gale, R; Linch, DC; Khwaja, A; (2006) Primary erythroblasts from patients with polycythaemia vera (PV) have a distinct gene expression signature from both idiopathic erythrocytosis (IE) and normal controls which shows limited changes in Jak-STAT target genes. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 79 - 79). BLACKWELL PUBLISHING

Everington, TF; Linch, DC; Khwaja, A; (2006) Reversal of apoptosis resistance and erythropoietin independent growth of primary erythroid progenitors from patients with polycythaemia vera (PV) by inhibitors of the Jak2 tyrosine kinase. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 33 - 34). BLACKWELL PUBLISHING

F

Filipe-Santos, O; Bustamante, J; Chapgier, A; Vogt, G; de Beaucoudrey, L; Feinberg, J; Jouanguy, E; ... Casanova, J-L; + view all (2006) Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. SEMINARS IN IMMUNOLOGY , 18 (6) pp. 347-361. 10.1016/j.smim.2006.07.010.

Filipe-Santos, O; Bustamante, J; Haverkamp, MH; Vinolo, E; Ku, C-L; Puel, A; Frucht, DM; ... Casanova, J-L; + view all (2006) X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. J Exp Med , 203 (7) pp. 1745-1759. 10.1084/jem.20060085.

Finnegan, DPJ; Kettle, P; Drake, M; Matthews, C; Alexander, HD; Popat, R; Cavanagh, JD; ... Morris, TCM; + view all (2006) Bortezomib is effective in primary plasma cell leukemia. LEUKEMIA & LYMPHOMA , 47 (8) pp. 1670-1673. 10.1080/10428190500520954.

Fitzmaurice, DA; Gardiner, C; Kitchen, S; Mackie, I; Murray, ET; Machin, SJ; (2006) Erratum: An evidence based review and guidelines for patient self-testing and management of oral anticoagulation (British Journal of Haematology (2005) 131 (156-165)). British Journal of Haematology , 132 (1) 118-. 10.1111/j.1365-2141.2005.05830.x.

Florijn, RJ; Loves, W; Wenniger-Prick, LJJMMD; Mannens, MMAM; Tijmes, N; Brooks, SP; Hardcastle, AJ; (2006) New mutations in the NHS gene in Nance-Horan Syndrome families from the Netherlands. EUR J HUM GENET , 14 (9) 986 - 990. 10.1038/sj.ejhg.5201671.

Fung, EB; Harmatz, PR; Lee, PDK; Milet, M; Bellevue, R; Jeng, MR; Kalinyak, KA; ... Multi-Centre Study of Iron Overload Research Group, ; + view all (2006) Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease. Br J Haematol , 135 (4) pp. 574-582. 10.1111/j.1365-2141.2006.06332.x.

G

Gale, RE; Allen, AJR; Nash, MJ; Linch, DC; (2006) Lack of correlation of clonality status with the level of Val617Phe JAK2 mutant in essential thrombocythaemia (ET) indicates that the JAK2 when present, is not the primary pathogenic event. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 12 - 12). BLACKWELL PUBLISHING

Gale, RE; Hills, R; Wheatley, K; Burnett, AK; Linch, DC; (2006) Response: Allogeneic stem cell transplantation and FLT3/ITD status in AML. BLOOD , 108 (1) 400 - 401.

Garcia, CA; Robinson, J; Guethlein, LA; Vilches, C; Parham, P; Madrigal, JA; Marsh, SGE; (2006) Human Killer-cell Immunoglobulin-like Receptor (KIR) polymorphism. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 1208-1232). IHWG Press: Seattle.

Garcia, CA; Robinson, J; Shilling, HG; Guethlein, LA; Parham, P; Madrigal, JA; Marsh, SGE; (2006) KIR gene characterisation of HLA homozygous cell lines. In Immunobiology of the Human MHC. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 1203-1207). IHWG Press: Seattle.

Garcia-Ortiz, JE; Sandoval-Ramirez, L; Rangel-Villalobos, H; Maldonado-Torres, H; Cox, S; Garcia-Sepulveda, CA; Figuera, LE; ... Arguello, JR; + view all (2006) High-resolution molecular characterization of the HLA class I and class II in the Tarahumara Amerindian population. TISSUE ANTIGENS , 68 (2) pp. 135-146. 10.1111/j.1399-0039.2006.00636.x.

Gardiner, C; Cohen, H; Austin, SK; Machin, SJ; Mackie, IJ; (2006) Pregnancy loss, tissue factor pathway inhibitor deficiency and resistance to activated protein C. J THROMB HAEMOST , 4 (12) 2724 - 2726.

Gardiner, C; Cohen, H; Austin, SK; Machin, SJ; Mackie, IJ; (2006) Pregnancy loss, tissue factor pathway inhibitor deficiency and resistance to activated protein C. Journal of thrombosis and haemostasis : JTH , 4 pp. 2724-2726.

Gardiner, C; Cohen, H; Jenkins, A; Machin, SJ; Mackie, IJ; (2006) Detection of acquired resistance to activated protein C associated with antiphospholipid antibodies using a novel clotting assay. BLOOD COAGUL FIBRIN , 17 (6) 477 - 483.

Gardiner, C; Kitchen, S; Dauer, RJ; Kottke-Marchant, K; Adcock, DM; (2006) Recommendations for evaluation of coagulation analyzers. Lab Hematol , 12 (1) pp. 32-38. 10.1532/LH96.05031.

Gardiner, C; Williams, K; Longair, I; Mackie, IJ; Machin, SJ; Cohen, H; (2006) A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing. BRIT J HAEMATOL , 132 (5) 598 - 603. 10.1111/j.1365-2141.2005.05899.x.

Gardiner, C; Williams, K; Mackie, IJ; Machin, SJ; Cohen, H; (2006) Can oral anticoagulation be managed using telemedicine and patient self-testing? A pilot study. CLIN LAB HAEMATOL , 28 (2) 122 - 125.

Gerrard, G; Mitchell, W; Patel, B; Goldstone, A; Fielding, A; Foroni, L; (2006) Minimal residual disease monitoring of BCR-ABL(+) adult acute lymphoblastic leukaemia using quantitative real-time PCR: preliminary results from the UKALLXII trial. In: (Proceedings) 46th Annual Scientific Meetign of the British-Society-for-Haematology. (pp. pp. 53-54). BLACKWELL PUBLISHING

Glanville, J; Eleftheriou, P; Porter, J; (2006) MRI evidence of cardiac accumulation in myelodysplasia and unusual anaemias. In: BLOOD. (pp. 446A - 446A). AMER SOC HEMATOLOGY

Glasow, A; Barrett, A; Boix i Chornet, M; Gupta, R; Zhou, D-C; Gallagher, R; von Lindern, M; ... Zelent, A; + view all (2006) DNA methylation independent silencing of the RAR alpha gene expression in acute myeloid leukemia. In: (Proceedings) 48th Annual Meeting of the American-Society-of-Hematology. (pp. 630A-631A). AMER SOC HEMATOLOGY

Goodwin, S; Richfield, L; Milligan, A; Bruce, R; Blincoe, M; Hughes, D; Mehta, A; ... Elliott, P; + view all (2006) A pitfall in screening for Anderson-Fabry disease in patients with hypertrophic cardiomyopathy - a case report. Presented at: UNSPECIFIED.

Grandage, VL; Everington, T; Linch, DC; Khwaja, A; (2006) Go6976 is a potent inhibitor of the JAK 2 and FLT3 tyrosine kinases with significant activity in primary acute myeloid leukaemia cells. BRIT J HAEMATOL , 135 (3) 303 - 316. 10.1111/j.1365-2141.2006.06291.x.

Gross, D-A; Chappert, P; Leboeuf, M; Monteilhet, V; Van Wittenberghe, L; Danos, O; Davoust, J; (2006) Simple conditioning with monospecific CD4+CD25+ regulatory T cells for bone marrow engraftment and tolerance to multiple gene products. Blood , 108 (6) pp. 1841-1848. 10.1182/blood-2006-02-011981.

Gutierrez-Rodriguez, ME; Sandoval-Ramirez, L; Diaz-Flores, M; Marsh, SGE; Valladares-Salgado, A; Madrigal, JA; Mejia-Arangure, JM; ... Cruz, M; + view all (2006) KIR gene in ethnic and Mestizo populations from Mexico. Human Immunology , 68 pp. 135-146.

Gutierrez-Rodriguez, ME; Sandoval-Ramirez, L; Diaz-Flores, M; Marsh, SGE; Valladares-Salgado, A; Madrigal, JA; Mejia-Arangure, JM; ... Cruz, M; + view all (2006) KIR gene in ethnic and mestizo populations from Mexico. HUMAN IMMUNOLOGY , 67 (1-2) pp. 85-93. 10.1016/j.humimm.2005.11.007.

H

Hajioff, D; Hegemann, S; Conti, G; Beck, M; Sunder-Plassmann, G; Widmer, U; Mehta, A; (2006) 6 Agalsidase alpha and hearing in Fabry disease: data from the Fabry Outcome Survey. European Journal of Clinical Investigation , 36 (9) pp. 663-667.

Hegemann, S; Hajioff, D; Conti, G; Beck, M; Sunder-Plassmann, G; Widmer, U; Mehta, A; (2006) Hearing loss in Fabry disease: data from the Fabry Outcome Survey. European Journal of Clinical Investigation , 36 (9) pp. 654-662.

Hernandez, D; Chandan, P; Janmohamed, A; Phillips, LR; Shephard, EA; (2006) Deletion of genes from the mouse genome using Cre/loxP technology. In: UNSPECIFIED (pp. 307-319).

Hernandez, D; I R, S; E, A; (2006) Characterization of targeted mouse embryonic stem cells. In: Phillips, IR and Shephard, EA, (eds.) Cytochrome P450 protocols. (pp. 321-327). Humana Press: Totowa, New Jersey.

Hernandez, D; Melidoni, AN; Phillips, LR; Shephard, EA; (2006) Microinjection of targeted embryonic stem cells and establishment of knockout mouse lines for Fmo genes. In: UNSPECIFIED (pp. 329-341).

Hollak, CEM; Hughes, D; Schwierin, B; Bembi, B; (2006) IS3: An approach to safety monitoring in daily practice. J INHERIT METAB DIS , 29 42 - 42.

Hollak, CEM; Hughes, D; Van Schaik, IN; Giraldo, P; Marodi, L; Beck, M; Niederau, C; (2006) An observational prospective study of neurological manifestations, and other comorbidities in adult type 1 Gaucher disease. Presented at: UNSPECIFIED.

Holmes, AM; Baker, RJ; Reed, MC; Richfield, L; Milligan, A; Bruce, R; Blincoe, M; ... Hughes, DA; + view all (2006) Adhesion of cultured macrophages predicts clinical phenotype in Anderson-Fabry disease. Presented at: UNSPECIFIED.

Hsu, KC; Bignon, JD; Carrington, M; Chida, S; Christiansen, F; De Santis, D; Eljaafari, A; ... Dupont, B; + view all (2006) 13th IHWS NK/KIR Joint Report. Killer immunoglobulin-like receptor genotypes, haplotypes and haplotype segregation patterns evaluated in the workshop KIR reference DNA panel. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 1169-1199). IHWG Press: Seattle.

Hughes, DA; (2006) The use of scoring systems in patients with haematological malignancy. ACTA PAEDIATRICA , 95 47 - 51. 10.1080/08035320600618866.

Hughes, DA; Duke, V; Baker, RJ; Wright, F; Foronii, L; Mehta, AB; (2006) High prevalence of B-cell clonality in Gaucher disease. Presented at: UNSPECIFIED.

Hughes, DA; Li, A; Holmes, AM; Reed, MC; Baker, RJ; Milligan, A; Richfield, L; ... Mehta, AB; + view all (2006) Anaemia in Anderson-Fabry disease: the role of hepcidin. Presented at: UNSPECIFIED.

Hughes, DA; Reed, M; Baker, RJ; Richfield, L; Milligan, A; Evans, S; Blincoe, M; ... Mehta, A; + view all (2006) Enhanced differentiation of osteoclasts from mononuclear precursors in patients with Gaucher disease. J INHERIT METAB DIS , 29 21 - 21.

I

Ings, SJ; Balsa, C; Leverett, D; Mackinnon, S; Linch, DC; Watts, MJ; (2006) Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used. BRIT J HAEMATOL , 134 (5) 517 - 525. 10.1111/j.1365-2141.2006.06223.x.

K

Kalve, I; Devitt, D; Little, AM; Liu, X; Tilanus, M; Marsh, SGE; Madrigal, JA; (2006) Evaluation of RSCA® as a novel, emerging HLA typing method. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 295-303). IHWG Press: Seattle.

Khwaja, A; (2006) The role of Janus kinases in haemopoiesis and haematological malignancy. BRIT J HAEMATOL , 134 (4) 366 - 384. 10.1111/j.1365-2141.2006.06206.x.

Kim, BS; Miyagawa, F; Bennett, CL; Clausen, BE; Katz, SI; (2006) Elimination of epidermal Langerhans cells or impairment of dermal dendritic cells does not abrogate the induction of localized graft-versus-host-disease-like skin disease. In: (Proceedings) 67th Annual Meeting of the Society-for-Investigative-Dermatology. (pp. p. 119). NATURE PUBLISHING GROUP

Kleinert, J; Dehout, F; Schwarting, A; de, LAG; Ricci, R; Kampmann, C; Beck, M; ... Sunder-Plassmann, G; + view all (2006) Prevalence of uncontrolled hypertension in patients with Fabry disease. American Journal of Hypertension , 19 (8) pp. 782-787.

Korman, AJ; Peggs, KS; Allison, JP; (2006) Checkpoint blockade in cancer immunotherapy. ADV IMMUNOL , 90 297 - 339. 10.1016/S0065-2776(06)90008-X.

Kottaridis, P.D.; (2006) Investigations of FLT3 internal tandem duplications in patients with acute myeloid leukaemia. Doctoral thesis , University of London. Green open access
file

Kyriakou, C; Davies, M; Chatterjee, R; Castleton, A; Roberts, K; Peniket, A; Mackinnon, S; (2006) Female gonadal function following reduced intensity conditioning (RIC) allogeneic bone marrow transplantation for haematological malignancies. In: BLOOD. (pp. 962A - 963A). AMER SOC HEMATOLOGY

Kyriakou, C; Rabin, N; Nathwani, A; Pizzey, A; Linch, DC; Yong, K; (2006) Factors influencing short term in vivo biodistribution of human bone marrow derived mesenchymal stem cells (hMSCs) in a xenogeneic animal model. In: BLOOD. (pp. 908A - 908A). AMER SOC HEMATOLOGY

Kyriakou, CA; Yong, KL; Benjamin, R; Pizzey, A; Dogan, A; Singh, N; Davidoff, AM; (2006) Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk-1) following lentiviral-mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model. J GENE MED , 8 (3) 253 - 264. 10.1002/jgm.840.

L

Lawrie, AS; Cardigan, R; Williamson, LW; Machin, SJ; Mackie, IJ; (2006) Fresh-frozen plasma (FFP) quality assessed by dynamics of the clotting process. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 118 - 119). BLACKWELL PUBLISHING

Lidove, O; Ramaswami, U; Jaussaud, R; Barbey, F; Maisonobe, T; Caillaud, C; Beck, M; ... Mehta, A; + view all (2006) Hyperhidrosis: a new and often early symptom in Fabry disease. International experience and data from the Fabry Outcome Survey. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , 60 (9) pp. 1053-1059. 10.1111/j.1742-1241.2006.01061.x.

Lidove, O; Ramaswami, U; Jaussaud, R; Barbey, F; Maisonobe, T; Caillaud, C; Beck, M; ... FOS European investigators, ; + view all (2006) Hyperhidrosis: a new and often early symptom in Fabry disease. International experience and data from the Fabry Outcome Survey. Int J Clin Pract , 60 (9) pp. 1053-1059. 10.1111/j.1742-1241.2006.01061.x.

Linhart, A; Hughes, DA; (2006) Age adjusted severity scoring for Fabry disease. Presented at: UNSPECIFIED.

Longair, I; Gardiner, C; Pescott, MA; Erwin, H; Mackie, IJ; Machin, SJ; (2006) An evaluation of HemoSense (TM) INRatio prothrombin time monitoring system. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 40 - 40). BLACKWELL PUBLISHING

Lovell, R; Delgado, J; Thomson, K; Russell, N; Ewing, J; Stewart, W; Marks, D; ... Milligan, D; + view all (2006) Results of alemtuzumab-based reduced-intensity allogeneic transplantation for advanced chronic lymphocytic leukaemia: a BSBMT study. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 66 - 67). BLACKWELL PUBLISHING

Lowdell, MW; Bakhsh, I; North, J; Marden, C; Addison, E; Mackinnon, S; (2006) Tumor-activated human NK cells specificall ylyse autologous and allogeneic NK-resistant tumor targets. In: BLOOD. (pp. 1059A - 1059A). AMER SOC HEMATOLOGY

M

Maharaj, L; Popat, R; Chahwan, A; Lister, AT; Cavenagh, JD; Middleton, B; Rioja, A; ... Joel, SP; + view all (2006) The novel HDAC inhibitor UCL67022 is highly potent in multiple myeloma and non-Hodgkin's lymphoma and is enhanced by bortezomib. In: (Proceedings) 48th Annual Meeting of the American-Society-of-Hematology. (pp. 735A-735A). AMER SOC HEMATOLOGY

Mansour, MR; (2006) A role for aberrant Notch signaling in acute myeloid leukemia? LEUKEMIA & LYMPHOMA , 47 (11) pp. 2280-2281. 10.1080/10428190600908109.

Mansour, MR; Linch, DC; Foroni, L; Goldstone, AH; (2006) High incidence of Notch-1 mutations in adult patients with T-cell acute lymphoblastic leukemia. LEUKEMIA , 20 (3) 537 - 539. 10.1038/sj.leu.2404101.

Mansour, MR; Linch, DC; Foroni, L; Goldstone, AH; Gale, RE; (2006) High incidence of Notch-1 mutations in adult patients with T-cell acute lymphoblastic leukemia [12]. Leukemia , 20 (3) pp. 537-539. 10.1038/sj.leu.2404101.

Mantovani, J; Holic, N; Martinez, K; Danos, O; Perea, J; (2006) A high throughput method for genome-wide analysis of retroviral integration. Nucleic Acids Res , 34 (19) , Article e134. 10.1093/nar/gkl716.

Marquis, J; Paillard, L; Audic, Y; Cosson, B; Danos, O; Le Bec, C; Osborne, HB; (2006) CUG-BP1/CELF1 requires UGU-rich sequences for high-affinity binding. Biochem J , 400 (2) pp. 291-301. 10.1042/BJ20060490.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, February 2006 update. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 33 (3) pp. 227-228. 10.1111/j.1744-313X.2006.00590.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, January 2006 update. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 33 (3) pp. 225-226. 10.1111/j.1744-313X.2006.00589.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, October 2005 update*. Int J Immunogenet , 33 (1) pp. 63-64. 10.1111/j.1744-313X.2006.00566.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update April 2006. TISSUE ANTIGENS , 68 (3) pp. 270-272. 10.1111/j.1399-0039.2006.00655.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update August 2006. TISSUE ANTIGENS , 68 (6) pp. 537-539. 10.1111/j.1399-0039.2006.00711.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update December 2005. TISSUE ANTIGENS , 67 (3) pp. 262-264. 10.1111/j.1399-0039.2006.00564.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update December 2005. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 33 (2) pp. 147-149. 10.1111/j.1744-313X.2006.00576.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update February 2006. TISSUE ANTIGENS , 67 (5) pp. 440-442. 10.1111/j.1399-0039.2006.00601.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update January 2006. TISSUE ANTIGENS , 67 (5) pp. 438-439. 10.1111/j.1399-0039.2006.00597.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update July 2006. HUMAN IMMUNOLOGY , 67 (12) pp. 1017-1018. 10.1016/j.humimm.2006.10.001.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update July 2006. TISSUE ANTIGENS , 68 (6) pp. 535-536. 10.1111/j.1399-0039.2006.00709.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update June 2006. TISSUE ANTIGENS , 68 (3) pp. 276-277. 10.1111/j.1399-0039.2006.00659.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update March 2006. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 33 (3) pp. 229-230. 10.1111/j.1744-313X.2006.00602.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update March 2006. TISSUE ANTIGENS , 68 (1) pp. 100-102. 10.1111/j.1399-0039.2006.00617.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update May 2006. TISSUE ANTIGENS , 68 (3) pp. 273-275. 10.1111/j.1399-0039.2006.00660.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update November 2005. TISSUE ANTIGENS , 67 (3) pp. 260-261. 10.1111/j.1399-0039.2006.00561.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update November 2005. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 33 (2) pp. 145-146. 10.1111/j.1744-313X.2006.00575.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update October 2005. TISSUE ANTIGENS , 67 (3) pp. 258-259. 10.1111/j.1399-0039.2005.00545.x.

Marsh, SGE; Parham, P; Dupont, B; Geraghty, DE; Trowsdale, J; Middleton, D; Vilches, C; ... Wain, H; + view all (2006) Killer-cell Immunoglobulin-like Receptor (KIR) Nomenclature Report, 2002. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 1196-1202). IHWG Press: Seattle.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2006) Nomenclature for factors of the HLA system, update September 2006. Tissue Antigens , 68 (6) pp. 540-542. 10.1111/j.1399-0039.2006.00713.x.

Mason, AJ; Martinez, A; Glaubitz, C; Danos, O; Kichler, A; Bechinger, B; (2006) The antibiotic and DNA-transfecting peptide LAH4 selectively associates with, and disorders, anionic lipids in mixed membranes. FASEB J , 20 (2) pp. 320-322. 10.1096/fj.05-4293fje.

Mayor, NP; Shaw, BE; Derralynn, AH; Maldonado-Torres, H; Madrigal, JA; Keshav, S; Marsh, SGE; (2006) Single nucleotide polymorphisms of the NOD2/CARD15 gene are associated with significant increases in disease relapse and mortality in recipients of an unrelated donor haematopoietic stem cell transplant for acute leukaemia. In: BLOOD. (pp. 151A - 151A). AMER SOC HEMATOLOGY

McCarville, MB; Streck, CJ; Dickson, PV; Li, CS; Nathwani, AC; Davidoff, AM; (2006) Angiogenesis inhibitors in a murine neuroblastoma model: Quantitative assessment of intratumoral blood flow with contrast-enhanced gray-scale US. RADIOLOGY , 240 (1) 73 - 81. 10.1148/radiol.2401050709.

McCarville, MB; Streck, CJ; Dickson, PV; Li, CS; Nathwani, AC; Davidoff, AM; (2006) Angiogenesis inhibitors in a murine neuroblastoma model: Quantitative assessment of intratumoral blood flow with contrast-enhanced gray-scale US. Radiology , 240 (1) pp. 73-81. 10.1148/radiol.2401050709.

McIntosh, JH; Cochrane, M; Prizzey, A; Waldmann, H; Davidoff, AM; Nathwani, AC; (2006) Successful Readministration of AAV8 Following Administration of Nondepleting CD4 Antibody at the Time of Vector Administration. MOLECULAR THERAPY , 13 S190-S190. 10.1016/j.ymthe.2006.08.560.

Mcintosh, J; Cochrane, M; Tuddenham, EGD; Davidoff, AM; Nathwani, AC; (2006) Expression of human FIX at therapeutic levels in nonhuman primates following a single peripheral vein infusion of low doses of self complementary AAV vector renews hope for haemophilia B gene therapy. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 18 - 18). BLACKWELL PUBLISHING

Mead, AJ; Linch, DC; Hills, R; Wheatley, K; Burnett, AK; Gale, RE; (2006) The favourable prognostic impact of tyrosine kinase domain mutations of FLT3 in AML is related to the level of mutation. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 106 - 106). BLACKWELL PUBLISHING

Mehta, A; (2006) Clinical experience with substrate reduction therapy. European Journal of Internal Medicine , 17 S13-15.

Mehta, A; (2006) Epidemiology and natural history of Gaucher's disease. European Journal of Internal Medicine (17) S2-S5.

Mickelson, E; Hurley, C; Ng, J; Tilanus, M; Carrington, M; Marsh, SGE; Rozemuller, E; ... Hansen, J; + view all (2006) 13th IHWS Shared Resources Joint Report. IHWG Cell and Gene Bank and reference cell panels. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 523-553). IHWG Press: Seattle.

Middleton, D; Meenagh, A; Marsh, SGE; Martin, J; (2006) A HLA-Cw*03 allele, Cw*0322Q with limited or no expression. TISSUE ANTIGENS , 67 (4) pp. 343-345. 10.1111/j.1399-0039.2006.00571.x.

Milligan, A; Baker, R; Blincoe, M; Bruce, R; Goodwin, S; Holmes, A; Hughes, D; ... Mehta, A; + view all (2006) Anderson-Fabry disease: the descendants of William Anderson's first patient followed into the 21st century. Presented at: UNSPECIFIED.

Milligan, A; Hughes, D; Goodwin, S; Richfield, L; Mehta, A; (2006) Intravenous enzyme replacement therapy: better in home or hospital? Br J Nurs , 15 (6) pp. 330-333. 10.12968/bjon.2006.15.6.20681.

Miro, F; Nobile, C; Blanchard, N; Lind, M; Filipe-Santos, O; Fieschi, C; Chapgier, A; ... Hivroz, C; + view all (2006) T cell-dependent activation of dendritic cells requires IL-12 and IFN-gamma signaling in T cells. JOURNAL OF IMMUNOLOGY , 177 (6) pp. 3625-3634. 10.4049/jimmunol.177.6.3625.

Moran, J; Verfuerth, S; Peggs, K; Mackinnon, S; (2006) Impact of CMV-specific immunotherapy on duration and cost of anti-viral therapy. In: BONE MARROW TRANSPLANTATION. (pp. S265 - S265). NATURE PUBLISHING GROUP

Morsi, H; Yong, KL; Jewell, AP; (2006) Preferential survival of acute lymphoblastic leukemia cells at 33 degrees C is associated with up-regulation of bcl-2. LEUKEMIA LYMPHOMA , 47 (6) 1117 - 1122. 10.1080/10428190500404498.

Mudie, N.Y.; Swerdlow, A.J.; Higgins, C.D.; Smith, P.; Qiao, Z.; Hancock, B.W.; Hoskin, P.J.; (2006) Risk of second malignancy after non-Hodgkin's lymphoma: a British cohort study. Journal of Clinical Oncology , 24 (10) pp. 1568-1574. 10.1200/JCO.2005.04.2200.

Mudie, NY; Swerdlow, AJ; Higgins, CD; Smith, P; Qiao, ZK; Hancock, BW; Hoskin, PJ; (2006) Risk of second malignancy after non-Hodgkin's lymphoma: A British cohort study. J CLIN ONCOL , 24 (10) 1568 - 1574. 10.1200/JCO.2005.04.2200.

N

Nathwani, AC; Gray, JT; Ng, CYC; Zhou, JF; Spence, Y; Waddington, SN; Tuddenham, EGD; ... Davidoff, AM; + view all (2006) Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver. BLOOD , 107 (7) 2653 - 2661. 10.1182/blood-2005-10-4035. Gold open access

O

Olivier, A; Jeanson-Leh, L; Bouma, G; Compagno, D; Blondeau, J; Seye, K; Charrier, S; ... Galy, A; + view all (2006) A partial down-regulation of WASP is sufficient to inhibit podosome formation in dendritic cells. MOL THER , 13 (4) 729 - 737. 10.1016/j.ymthe.2005.11.003.

P

Pamphilon, D; Mackinnon, S; Nacheva, E; Russell, N; Wilson, K; Clay, M; Miller, J; ... Contreras, M; + view all (2006) The use of granulocyte colony-stimulating factor in volunteer blood and marrow registry donors. Bone Marrow Transplant , 38 (10) pp. 699-700. 10.1038/sj.bmt.1705508.

Paston, S.J.; (2006) CMV epitope selection and its use in T cell reconstitution in patients undergoing haematopoietic stem cell transplantation. Doctoral thesis , University of London. Green open access
file

Patel, BR; Goldstone, AH; Ross, P; Foroni, L; Richards, S; Chopra, R; Fielding, AK; (2006) Clinical effect of Imatinib following remission induction in adult Philadelphia chromosome-positive acute lymphoblastic leukaemia: early results from the MRC UKALL12 Study. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 56 - 56). BLACKWELL PUBLISHING

Pawelec, G; Marsh, SG; (2006) ESTDAB: a collection of immunologically characterised melanoma cell lines and searchable databank. CANCER IMMUNOLOGY IMMUNOTHERAPY , 55 (6) pp. 623-627. 10.1007/s00262-005-0117-3.

Peggs, KS; (2006) Improving cellular therapies in Epstein-Barr virus-associated Hodgkin's lymphoma: shifting the equilibrium between effectors and regulators - Commentary on: Bollard et al. In vivo expansion of LMP 1-and 2-specific T-cells in a patient who received donor-derived EBV-specific T-cells after allogeneic stem cell transplantation. Leuk Lymphoma 2006; 47 : 837-842. LEUKEMIA LYMPHOMA , 47 (5) 787 - 789. 10.1080/10428190600648630.

Peggs, KS; (2006) Reconstitution of adaptive and innate immunity following allogeneic hematopoietic stem cell transplantation in humans. CYTOTHERAPY , 8 (5) 427 - 436. 10.1080/14653240600851938.

Peggs, KS; Quezada, SA; Korman, AJ; Allison, JP; (2006) Principles and use of anti-CTLA4 antibody in human cancer immunotherapy. CURR OPIN IMMUNOL , 18 (2) 206 - 213. 10.1016/j.coi.2006.01.011.

Pescott, MA; Gardiner, C; Erwin, H; Machin, SJ; Cohen, H; (2006) Acceptability of patient self-testing/self-management of oral anticoagulation in new patients. Presented at: 46th Annual Scientific Meeting of the British-Society-for-Haematology, Edinburgh, SCOTLAND.

Pescott, MA; Longair, I; Gardiner, C; Austin, SK; Machin, SJ; (2006) Acceptibility of patient self-testing of oral anticoagulation in new patients. In: (pp. p. 4122).

Pescott, MA; Longair, I; Gardiner, C; Austin, SK; Machin, SJ; (2006) Acceptibility of patient self-testing of oral anticoagulation in new patients. In: (Proceedings) 48th Annual Meeting of the American-Society-of-Hematology. (pp. 110B-110B). AMER SOC HEMATOLOGY

Picard, C; Filipe-Santos, O; Chapgier, A; von Bernuth, H; Vogt, G; Casanova, J-L; (2006) Genetic predisposition and children infectious disease. ARCHIVES DE PEDIATRIE , 13 (10) pp. 1342-1346. 10.1016/j.arcped.2006.07.009.

Popat, R; Goff, L; Oakervee, H; Cavenagh, JD; Joel, SP; (2006) Schedule dependent effect of bortezomib and melphalan for multiple myeloma associated with changes in Mcl-1 expression. In: (Proceedings) 46th Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 99). WILEY-BLACKWELL PUBLISHING, INC

Popat, R; Joel, S; Oakervee, H; Cavenagh, J; (2006) Bortezomib for multiple myeloma. Expert Opin Pharmacother , 7 (10) pp. 1337-1346. 10.1517/14656566.7.10.1337.

Popat, R; Oakervee, H; Curry, N; Foot, N; Morris, C; Drake, M; Agrawal, S; ... Cavenagh, JD; + view all (2006) Low dose PAD combination therapy (PS-341/bortezomib, adriamycin and dexamethasone) for untreated multiple myeloma. In: (Proceedings) 46th Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 99). WILEY-BLACKWELL PUBLISHING, INC

Popat, R; Oakervee, HE; Foot, N; Agrawal, S; Odeh, L; Craddock, C; Williams, C; ... Cavenagh, JD; + view all (2006) Low dose intravenous melphalan and bortezomib for relapsed multiple myeloma. In: (Proceedings) 46th Annual Scientific Meetign of the British-Society-for-Haematology. (pp. p. 98). BLACKWELL PUBLISHING

Popat, R; Williams, C; Cook, M; Craddock, C; Basu, S; Singer, C; Odeh, L; ... Cavenagh, JD; + view all (2006) A phase I/II trial of bortezomib, low dose intravenous melphalan and dexamethasone for patients with relapsed multiple myeloma. In: (Proceedings) 48th Annual Meeting of the American-Society-of-Hematology. (pp. 1011A-1011A). AMER SOC HEMATOLOGY

Porter, JB; (2006) Deferasirox: An effective once-daily orally active iron chelator. DRUG TODAY , 42 (10) 623 - 637. 10.1358/dot.2006.42.10.1009901.

Porter, JB; Cohen, A; Agaoglu, L; Ganser, A; Cappellini, MD; Maseruka, H; Glimm, E; ... Cappellini, MD; + view all (2006) Long-term effects of deferasirox (Exjade (R), ICL670) on serum ferritin: Outcome of dose adjustments in achieving maintenance or reduction in body iron stores. In: BLOOD. (pp. 502A - 502A). AMER SOC HEMATOLOGY

Porter, JC; Hall, A; (2006) Transepithelial migration (TEpM) of T lymphocytes is an active multi-step process resulting in their luminal clearance. In: JOURNAL OF IMMUNOLOGY. (pp. S39 - S39). AMER ASSOC IMMUNOLOGISTS

Posthouwer, D; Makris, M; Yee, TT; Fischer, K; Van Veen, J; Griffioen, A; Mauser-Bunschoten, EP; (2006) The natural history of hepatitis C in patients with bleeding disorders. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 20 - 20). BLACKWELL PUBLISHING

Posthouwer, D; Yee, TT; Makris, M; Fischer, K; Griffioen, A; Van Veen, J; Mauser-Bunschoten, EP; (2006) Response to antiviral therapy in patients with congenital bleeding disorders infected with hepatitis C. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 85 - 86). BLACKWELL PUBLISHING

Prieto-Hinojosa, A; Alejandro Madrigal, J; Shaw, BE; Mayor, NP; Marsh, SGE; Travers, PJ; Duarte, RF; (2006) High proportions of CD4+CD25(hi) T cells pretransplant correlate with worse overall survival after stem cell transplant. In: BLOOD. (pp. 891A - 892A). AMER SOC HEMATOLOGY

Q

Quezada, SA; Peggs, KS; Curran, MA; Allison, JP; (2006) CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells. J CLIN INVEST , 116 (7) 1935 - 1945. 10.1172/JCI27745. Green open access
file

R

Rabin, N; Kyriakou, C; Benjamin, R; Pizzey, A; Gallagher, O; Singh, N; Buckle, C; ... Yong, K; + view all (2006) Gene modified human mesenchymal stem cells expressing osteoprotegerin inhibit osteoclast activation and increase trabecular bone area in a xenogeneic murine model of myeloma. In: BLOOD. (pp. 153A - 153A). AMER SOC HEMATOLOGY

Rabin, N; Kyriakou, C; Pizzey, A; Buckle, C; Prideaux, M; Croucher, P; Nathwani, A; (2006) Gene Modified Human Mesenchymal Stem Cells Expressing Osteoprotegerin Reverse Osteoclast Activation in a Xenogeneic Murine Model of Multiple Myeloma. MOLECULAR THERAPY , 13 S256-S256. 10.1016/j.ymthe.2006.08.740.

Raeiszadeh, M; Kopycinski, J; Paston, SJ; Diss, T; Lowdell, M; Hardy, GAD; Hislop, AD; ... Webster, AD; + view all (2006) The T cell response to persistent herpes virus infections in common variable immunodeficiency. CLIN EXP IMMUNOL , 146 (2) 234 - 242. 10.1111/j.1365-2249.2006.03209.x.

Rafique, R; Mascarenhas, MSD; Ramesh, BS; Srai, KS; Porter, JB; (2006) DMT1-independent uptake of non-transferrin bound iron into human hepatoma cells is selectively modulated by T-type voltage-dependent calcium channel inhibitors. In: BLOOD. (pp. 443A - 443A). AMER SOC HEMATOLOGY

Ramaswami, U; Whybra, C; Parini, R; Pintos-Morell, G; Mehta, A; Sunder-Plassmann, G; Widmer, U; (2006) Clinical manifestations of Fabry disease in children: data from the Fabry Outcome Survey. Acta Paediatrica , 95 (1) pp. 86-92.

Reed, MC; Holmes, AM; Baker, RJ; Milligan, A; Richfield, L; Bruce, R; Goodwin, S; ... Hughes, DA; + view all (2006) Culture and characterization of osteoclasts in Gaucher disease. Presented at: UNSPECIFIED.

Remiszewski, P; Roszkowska-Sliz, B; Winek, J; Chapgier, A; Feinberg, J; Langfort, R; Bestry, I; ... Rowinska-Zakrzewska, E; + view all (2006) Disseminated Mycobacterium avium infection in a 20-year-old female with partial recessive IFN gamma R1 deficiency. RESPIRATION , 73 (3) pp. 375-378. 10.1159/000088682.

Richfield, L; Bruce, R; Baker, R; Goodwin, S; Holmes, A; Hughes, D; Milligan, A; (2006) Phenotypical expression of mutation R227X exon 5 of the GLA gene (nucleotide change p.Arg227X c.608C > T) identified in a large UK kindred spanning eight generations in a well-documented family pedigree. ACTA PAEDIATR , 95 127 - 128.

Rivière, C; Danos, O; Douar, AM; (2006) Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice. Gene Ther , 13 (17) pp. 1300-1308. 10.1038/sj.gt.3302766.

Robinson, J; Waller, MJ; Fail, SC; Marsh, SGE; (2006) The IMGT/HLA and IPD databases. HUMAN MUTATION , 27 (12) pp. 1192-1199. 10.1002/humu.20406.

Robinson, J; Waller, MJ; Parham, P; Marsh, SGE; (2006) IMGT/HLA and IMGT/MHC – sequence databases for the study of the major histocompatibility complex. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 442-447). IHWG Press: Seattle.

S

Schreuder, GMT; Hurley, CK; Marsh, SGE; Lau, M; Maiers, M; Kollman, C; Norren, HJ; (2006) The HLA Dictionary: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens In Immunobiology of the Human MHC. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 1117-1119). IHWG Press: Seattle.

Schwarting, A; Dehout, F; Feriozzi, S; Beck, M; Mehta, A; Sunder-Plassmann, G; (2006) Enzyme replacement therapy and renal function in 201 patients with Fabry disease. CLINICAL NEPHROLOGY , 66 (2) pp. 77-84.

Scully, M; Cavenagh, J; Benjamin, S; Mackie, I; Machin, S; Cohen, H; (2006) Disappearance of IgG antibody to ADAMTS 13 following rituximab in acute refractory thrombotic thrombocytopenic purpura. Presented at: 46th Annual Scientific Meeting of the British-Society-for-Haematology, Edinburgh, SCOTLAND.

Scully, M; Starke, R; Lee, R; Mackie, I; Machin, S; Cohen, H; (2006) Successful management of pregnancy in women with a history of TTP. Blood Coagulation and Fibrinolysis , 17 pp. 459-463.

Scully, M; Starke, R; Lee, R; Mackie, I; Machin, S; Cohen, H; (2006) Successful management of pregnancy in women with a history of thrombotic thrombocytopaenic purpura. BLOOD COAGUL FIBRIN , 17 (6) 459 - 463.

Scully, M; Starke, R; Mackie, I; Machin, SJ; (2006) Acute idiopathic thrombotic thrombocytopenic purpura: Predicting relapse and response to treatment. In: BLOOD. (pp. 315A - 315A). AMER SOC HEMATOLOGY

Scully, M; Yarranton, H; Liesner, R; Cavenagh, J; Hunt, B; Benjamin, S; Laffan, M; ... Machin, SJ; + view all (2006) The South East England thrombotic thrombocytopenic purpura registry. In: BLOOD. (pp. 317A - 317A). AMER SOC HEMATOLOGY

Shah, A; Peat, J; Maldonado-Torres, H; Marsh, SGE; Little, A-M; (2006) HLA-DQA1 and DQB1 alleles in Caucasoid and Asian donors from bone marrow registry. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 33 (4) p. 322.

Shah, JS; Hughes, D; Tayebjee, M; Macfadyen, R; Mehta, A; Elliott, PM; (2006) Extracellular matrix turnover and disease severity in Anderson-Fabry disease. In: ACTA PAEDIATR. (pp. 118 - 118). TAYLOR & FRANCIS AS

Shaw, BE; Boswell, T; Byrne, JL; Yates, C; Russell, NH; (2006) An MRSA outbreak in a stem cell transplant unit: analysis before and after a highly effective eradication strategy. In: BONE MARROW TRANSPLANTATION. (pp. S163 - S164). NATURE PUBLISHING GROUP

Shaw, BE; Byrne, JL; Das-Gupta, E; Carter, I; Russell, NH; (2006) Converting mixed chimerism to full donor chimerism in recipients of campath-containing reduced-intensity transplants reduces the relapse risk and improves survival compared to those with persistent full donor chimerism. In: BONE MARROW TRANSPLANTATION. (pp. S101 - S102). NATURE PUBLISHING GROUP

Shaw, BE; Byrne, JL; Das-Gupta, E; Carter, I; Russell, NH; (2006) Low pre-DLI lymphocytes counts are predictive of good disease responses in patients with mixed chimerism following campath-containing reduced intensity transplants. In: BLOOD. (pp. 81A - 81A). AMER SOC HEMATOLOGY

Shaw, BE; Marsh, SGE; Madrigal, JA; (2006) Role of HLA matching in unrelated donor transplant – An update of the Anthony Nolan data. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 1392-1394). IHWG Press: Seattle.

Shaw, BE; Marsh, SGE; Mayor, NP; Russell, NH; Madrigal, JA; (2006) HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants. BLOOD , 107 (3) 1220 - 1226. 10.1182/blood-2005-08-3121.

Shaw, BE; Marsh, SGE; Mayor, NP; Russell, NH; Madrigal, JA; (2006) HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants. Blood , 107 (3) pp. 1220-1226. 10.1182/blood-2005-08-3121. Green open access
file

Shaw, BE; Mufti, GJ; Mackinnon, S; Cavenagh, J; Towlson, K; Pearce, R; Pagliuca, A; ... Russell, NH; + view all (2006) Outcome of second allogeneic transplants using reduced intensity conditioning following relapse after an initial allogeneic transplant. In: BLOOD. (pp. 1045A - 1046A). AMER SOC HEMATOLOGY

Shaw, BE; Potter, MN; Prentice, HG; Mayor, N; Pay, AL; Marsh, SGE; Madrigal, JA; (2006) Graft versus host disease in matched T cell depleted unrelated donor haematopoietic stem cell transplants. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 635-638). IHWG Press: Seattle.

Shaw, BE; Potter, MN; Prentice, HG; Mayor, N; Pay, AL; Travers, P; Marsh, SGE; (2006) Disease relapse following volunteer donor haematopoietic stem cell transplantation. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 631-634). IHWG Press: Seattle.

Smith, A; Wisloff, F; Samson, D; (2006) Guidelines on the diagnosis and management of multiple myeloma 2005. BRITISH JOURNAL OF HAEMATOLOGY , 132 (4) pp. 410-451. 10.1111/j.1365-2141.2005.05867.x.

Soeiro, I; Mohamedali, A; Romanska, HM; Lea, NC; Child, ES; Glassford, J; Orr, SJ; ... Lam, EW-F; + view all (2006) p27Kip1 and p130 cooperate to regulate hematopoietic cell proliferation in vivo. Mol Cell Biol , 26 (16) pp. 6170-6184. 10.1128/MCB.02182-05.

Stainsby, D; Cohen, H; Jones, H; (2006) The 2005 annual SHOT report (on behalf of the serious hazards of transfusion steering group).

Stainsby, D; JONES, H; COHEN, H; (2006) A decade of haemovigilance: informing transfusion safety. In: (Proceedings) British society for haematology annual scientific meeting.

Stainsby, D; Jones, H; Asher, D; Atterbury, C; Boncinelli, A; Brant, L; Chapman, CE; ... Group, SS; + view all (2006) Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfusion medicine reviews , 20 pp. 273-282.

Starke, R; MacKie, I; Drummond, O; MacGregor, I; Harrison, P; MacHin, S; (2006) Prion protein in patients with renal failure. Transfusion Medicine , 16 (3) pp. 165-168. 10.1111/j.1365-3148.2006.00662.x.

Starke, R; Machin, S; Scully, M; Purdy, G; Mackie, I; (2006) ADAMTS13 antigen levels in 7 TTP patients studied longitudinally. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 48 - 48). BLACKWELL PUBLISHING

Starke, R; Mackie, I; Drummond, O; MacGregor, I; Harrison, P; Machin, S; (2006) Prion protein in patients with renal failure. TRANSFUSION MED , 16 (3) 165 - 168. 10.1111/j.1365-3148.2006.00662.x.

Steele, AJ; Jones, DT; Ganeshaguru, K; Duke, VM; Yogashangary, BC; North, JM; Lowdell, MW; ... Wickremasinghe, RG; + view all (2006) The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro. LEUKEMIA , 20 (6) 1073 - 1079. 10.1038/sj.leu.2404230.

Steele, AJ; Jones, DT; Ganeshaguru, K; Duke, VM; Yogashangary, BC; North, JM; Lowdell, MW; ... Wickremasinghe, RG; + view all (2006) The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro. Leukemia , 20 (6) pp. 1073-1079. 10.1038/sj.leu.2404230.

Steele, AJ; Prentice, AG; Hoffbrand, AV; Mehta, AB; Ganeshaguru, K; Wickremasinghe, RG; (2006) Generation of reactive oxygen species by parthenolide rapidly and selectively induces apoptosis of B-chronic lymphocytic leukaemia (CLL) cells via a p53 independent pathway. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 53 - 53). BLACKWELL PUBLISHING

Stewart, WA; Bomanji, JB; Mackinnon, S; Kottaridis, PD; (2006) Diffuse bowel fluorodeoxyglucose uptake on positron emission tomography scan following allogeneic stem cell transplant. Br J Haematol , 133 (3) 219-. 10.1111/j.1365-2141.2006.06040.x.

Streck, CJ; Dickson, PV; Ng, CYC; Zhou, J; Hall, MM; Gray, JT; Nathwani, AC; (2006) Antitumor efficacy of AAV-mediated systemic delivery of interferon-β. Cancer Gene Therapy , 13 (1) pp. 99-106. 10.1038/sj.cgt.7700878.

Symeonidis, A; Hughes, D; Richfield, L; Mehta, A; (2006) Variation of serum lipid profile during enzyme replacement therapy, in patients with type 1 gauchers disease. In: BLOOD. (pp. 39B - 39B). AMER SOC HEMATOLOGY

T

Thomson, K; Julie, M; Pang, K; Samuel, E; Desborough, M; Lowdell, MW; Mackinnon, S; (2006) Direct isolation of donor-derived antigen - Specific T cells and their adoptive transfer for treatment or prophylaxis of CMV infection following allogeneic transplantation. In: BLOOD. (pp. 177A - 178A). AMER SOC HEMATOLOGY

Thomson, KJ; Mackinnon, S; (2006) Role of allogeneic transplantation in low-grade lymphoma and chronic lymphocytic leukemia. CURR OPIN HEMATOL , 13 (4) 273 - 279.

Thomson, KJ; Mackinnon, S; Peggs, KS; (2006) T-cell depleted allogeneic haematopoietic stem cell transplantation and salvage donor lymphocyte infusions: a viable option in the era of reduced intensity transplantation? In: Davidson, DF, (ed.) Bone marrow transplantation. (pp. 57-82). Nova Biomedical

Tobar, JA; Carreno, LJ; Bueno, SM; Gonzalez, PA; Mora, JE; Quezada, SA; Kalergis, AM; (2006) Virulent Salmonella enterica serovar typhimurium evades adaptive immunity by preventing dendritic cells from activating T cells. INFECT IMMUN , 74 (11) 6438 - 6448. 10.1128/IAI.00063-06.

Travers, PJ; Knight, A; Grace, S; Kottaridis, P; Mackinnon, S; Madrigal, JA; (2006) Asymmetric reconstitution of gamma delta T cell subsets after haemopoietic stem cell transplantation. In: BLOOD. (pp. 823A - 824A). AMER SOC HEMATOLOGY

Tsolia, MN; Chapgier, A; Taprantzi, P; Servitzoglou, M; Tassios, I; Spyridis, N; Papageorgiou, F; ... Spyridis, P; + view all (2006) Disseminated nontuberculous mycobacterial infection in a child with interferon-gamma receptor 1 deficiency. EUROPEAN JOURNAL OF PEDIATRICS , 165 (7) pp. 458-461. 10.1007/s00431-006-0110-7.

U

Ungerechts, G; Springfeld, C; Fielding, A; Cattaneo, R; (2006) Next Generation Measles Virus Vectors for Oncolytic Therapy: Targeted, Armed and Stealth. MOLECULAR THERAPY , 13 S373-S373. 10.1016/j.ymthe.2006.08.1060.

V

Veron, P; Boutin, S; Bernard, J; Danos, O; Davoust, J; Masurier, C; (2006) Efficient transduction of monocyte- and CD34+-derived Langerhans cells with lentiviral vectors in the absence of phenotypic and functional maturation. J Gene Med , 8 (8) pp. 951-961. 10.1002/jgm.923.

Vig, S; Chitolie, A; Bevan, D; Dormandy, J; Thompson, MM; Halliday, A; (2006) The prevalence of thrombophilia in patients with symptomatic peripheral vascular disease. BRIT J SURG , 93 (5) 577 - 581. 10.1002/bjs.5300.

Vogt, G; Chapgier, A; Chuzhanova, N; Feinberg, J; Fieschi, C; Boisson-Dupuis, S; Alcais, A; ... Casanova, JL; + view all (2006) Gains of glycosylation mutations. M S-MEDECINE SCIENCES , 22 (5) pp. 480-482. 10.1051/medsci/2006225480.

W

Walter, PB; Fung, EB; Killilea, DW; Jiang, Q; Hudes, M; Madden, J; Porter, J; ... Harmatz, P; + view all (2006) Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease. BRIT J HAEMATOL , 135 (2) 254 - 263. 10.1111/j.1365-2141.2006.06277.x.

Walter, PB; Killilea, DW; Fung, EB; Lui, A; Madden, J; Porter, J; Evans, P; ... Harmatz, P; + view all (2006) Leukocyte apoptosis and inflammation in iron-overloaded patients with sickle cell disease or beta-thalassemia: A mechanism for increased stroke and disease severity in sickle cell disease. In: BLOOD. (pp. 363A - 363A). AMER SOC HEMATOLOGY

Westerman, M; Pizzey, A; Hirschman, J; Cerino, M; Well-Weiner, Y; Ramotar, P; Eze, A; ... Porter, J; + view all (2006) Plasma hemoglobin: Potential sources. In: BLOOD. (pp. 29B - 29B). AMER SOC HEMATOLOGY

Whitaker, DC; Stygall, J; Harrison, MJG; Mackie, IJ; Kemp, M; Hooper, J; Pugsley, WB; (2006) Leucocyte-depleting arterial line filtration does not reduce myocardial injury assessed by Troponin T during routine coronary artery bypass grafting using crossclamp fibrillation. PERFUSION-UK , 21 (1) 55 - 60. 10.1191/0267659106pf847oa.

Whitaker, DC; Stygall, J; Harrison, MJG; Mackie, IJ; Kemp, M; Hooper, J; Pugsley, WB; (2006) Leucocyte-depleting arterial line filtration does not reduce myocardial injury assessed by Troponin T during routine coronary artery bypass grafting using crossclamp fibrillation. Perfusion , 21 pp. 1-7.

Y

Yamaguchi, M; Fujimura, K; Toga, H; Khwaja, A; Okamura, N; Chopra, R; (2006) The SBDS gene regulates viability of myeloid precursor cells and is associated with high ROS production and telomere shortening in the SBDS downregulated cells. In: BLOOD. (pp. 468A - 468A). AMER SOC HEMATOLOGY

Yang, C-H; Jeng, K-CG; Yang, W-H; Chen, Y-L; Hung, C-C; Lin, J-W; Chen, S-T; ... Sheh, L; + view all (2006) Unusually strong positive cooperativity in binding of peptides to latent membrane protein-1 DNA fragments of the Epstein-Barr viral gene. CHEMBIOCHEM , 7 (8) pp. 1187-1196. 10.1002/cbic.200600083.

Z

Zhang, B; McGee, B; Yamaoka, JS; Guglielmone, H; Downes, KA; Minoldo, S; Jarchum, G; ... Ginsburg, D; + view all (2006) Combined deficiency of factor V and factor VIII is due to mutations in either LMAN1 or MCFD2. Blood , 107 (5) pp. 1903-1907. 10.1182/blood-2005-09-3620.

This list was generated on Sun May 26 05:06:50 2019 BST.